EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Long Non-Coding RNA Signatures in the Ileum and Colon of Crohn’s Disease Patients and Effect of Anti-TNF-α Treatment on Their Modulation

Montse Baldan-Martin iD, Cristina Rubín de Célix iD, Macarena Orejudo iD, Lorena Ortega Moreno iD, Samuel Fernández-Tomé iD, Irene Soleto iD, Cristina Ramirez, Ricardo Arroyo, Paloma Fernández, Cecilio Santander iD, José Andrés Moreno-Monteagudo, María José Casanova und 7 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242115691 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Montse Baldan-Martin und 18 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Universidad Autónoma de M…. Hauptthemen laut MEDLINE: Crohn Disease, RNA, Long Noncoding. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biological therapies only benefit one-third of patients with Crohn’s disease (CD). For this reason, a deeper understanding of the mechanisms by which biologics elicit their effect on intestinal mucosa is needed. Increasing evidence points toward the involvement of long noncoding RNAs (lncRNAs) in the pathogenesis of CD, although their role remains poorly studied. We aimed to characterize lncRNA profiles in the ileum and colon from CD patients and evaluate the effect of anti-TNF-α treatment on their transcription. Terminal ileum and left colon samples from 30 patients (active CD = 10, quiescent CD = 10, and healthy controls (HCs) = 10) were collected for RNA-seq. The patients were classified according to endoscopic activity. Furthermore, biopsies were cultured with infliximab, and their transcriptome was determined by Illumina gene expression array. A total of 678 differentially expressed lncRNAs between the terminal ileum and left colon were identified in HCs, 438 in patients with quiescent CD, and 468 in patients with active CD. Additionally, we identified three new lncRNAs in the ileum associated with CD activity. No differences were observed when comparing the effect of infliximab according to intestinal location, presence of disease (CD vs. HC), and activity (active vs. quiescent). The expression profiles of lncRNAs are associated with the location of intestinal tissue, being very different in the ileum and colon. The presence of CD and disease activity are associated with the differential expression of lncRNAs. No modulatory effect of infliximab has been observed in the lncRNA transcriptome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseRNA, Long NoncodingHumansInfliximabTumor Necrosis Factor InhibitorsTumor Necrosis Factor-alphaColonIleumIntestinal Mucosa

Stichwörter der Autor:innen

Crohn’s diseaseRNA seqanti-TNF-αbiological drugsinflammatory bowel diseaselncRNAlong noncoding RNA

Substanzen

RNA, Long NoncodingInfliximabTumor Necrosis Factor InhibitorsTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), Centro de Investigación Biomédica en Red de Enfermedades…
  • Área de Farmacología y Nutrición y Bromatología, Grupo de Investigación de Alto Rendimiento en Fisiopatología del Sistema Digestivo URJC: NeuGut-URJC, Departamento Ciencias Básicas de la Salud, Universidad Rey Juan Carl…
  • Departamento de Nutrición y Ciencia de los Alimentos, Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, Spain.
  • Instituto de Medicina Molecular Aplicada Nemesio Díez (IMMA-ND), Facultad de Medicina, Universidad San Pablo CEU, 28668 Madrid, Spain.
  • Bioinformatics Platform, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 08036 Barcelona, Spain.
  • Genome Analysis Platform, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 48160 Derio, Spain.

ORCID-Profile: Montse Baldan-Martin, Cristina Rubín de Célix, Macarena Orejudo, Lorena Ortega Moreno, Samuel Fernández-Tomé, Irene Soleto, Cecilio Santander, Ana M Aransay, María Chaparro, Javier P Gisbert

Zitieren

APA

Baldan-Martin, M., Rubín de Célix, C., Orejudo, M., Ortega Moreno, L., Fernández-Tomé, S., Soleto, I., Ramirez, C., Arroyo, R., Fernández, P., Santander, C., Moreno-Monteagudo, J. A., Casanova, M. J., Casals, F., Casabona, S., Becerro, I., Lozano, J. J., Aransay, A. M., Chaparro, M., & Gisbert, J. P. (2023). Long Non-Coding RNA Signatures in the Ileum and Colon of Crohn’s Disease Patients and Effect of Anti-TNF-α Treatment on Their Modulation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242115691

Vancouver

Baldan-Martin M, Rubín de Célix C, Orejudo M, Ortega Moreno L, Fernández-Tomé S, Soleto I, et al. Long Non-Coding RNA Signatures in the Ileum and Colon of Crohn’s Disease Patients and Effect of Anti-TNF-α Treatment on Their Modulation. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242115691

BibTeX
@article{BaldanMartin2023,
  author = {Baldan-Martin, Montse and Rubín de Célix, Cristina and Orejudo, Macarena and Ortega Moreno, Lorena and Fernández-Tomé, Samuel and Soleto, Irene and Ramirez, Cristina and Arroyo, Ricardo and Fernández, Paloma and Santander, Cecilio and Moreno-Monteagudo, José Andrés and Casanova, María José and Casals, Fernando and Casabona, Sergio and Becerro, Irene and Lozano, Juan J and Aransay, Ana M and Chaparro, María and Gisbert, Javier P},
  title = {Long Non-Coding RNA Signatures in the Ileum and Colon of Crohn’s Disease Patients and Effect of Anti-TNF-α Treatment on Their Modulation},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242115691}
}
Kostenlos starten →